Log In
Print
BCIQ
Print
Print this Print this
 

ABT-894

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionNeuronal nicotinic acetylcholine receptor (nAChR) agonist
Molecular Target Nicotinic receptor
Mechanism of ActionNicotinic receptor modulator
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD) in adults
Regulatory Designation

Partner

NeuroSearch A/S


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today